Ajoy Dias, M.D.

Ajoy Dias, M.D.

  • Center for Cancer Research
  • National Cancer Institute
Immune Deficiency Cellular Therapy Program


Dr. Dias's research focus is to diagnose and treat adult patients with inherited myeloid malignancies. His current work is with patients who have GATA 2 deficiency and myeloid malignancy. In the future he plans to develop protocols to optimize hematopoietic cell transplant regimens for adult inherited myeloid malignancies such as DDX-41, ANKRD26, ETV6 and other germline disorders predisposing to myeloid malignancies. His areas of interest include: 1) Diagnose and treat adult patients with germline predisposition to myeloid malignancies and 2) Improve long term outcomes of adult allogeneic transplant survivors with inherited myeloid malignancies.

Areas of Expertise

Adult Hematopoietic Cell Transplantation
GATA 2 Deficiency
Adult Inherited Myeloid Malignancies

Information for Patients

Learn more about our clinical trials and the highly specialized care teams who lead them.